TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover |
13,143
|
11,284
|
11,484 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
345
|
302
|
158 |
EBITDA |
558
|
310
|
174 |
Total assets |
5,317
|
4,477
|
4,662 |
Current assets |
4,473
|
4,450
|
4,627 |
Current liabilities |
1,520
|
1,249
|
1,600 |
Equity capital |
3,537
|
3,007
|
2,845 |
- share capital |
52
|
48
|
49 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency |
66.5%
|
67.2%
|
61.0% |
Turnover per employee |
4,381
|
3,761
|
3,828 |
Profit as a percentage of turnover |
2.6%
|
2.7%
|
1.4% |
Return on assets (ROA) |
6.5%
|
6.7%
|
3.4% |
Current ratio |
294.3%
|
356.3%
|
289.2% |
Return on equity (ROE) |
9.8%
|
10.0%
|
5.6% |
Change turnover |
875
|
98
|
160 |
Change turnover % |
7%
|
1%
![]() |
1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.